AIKIDO PHARMA INC., as ISSUER and [ ], as INDENTURE TRUSTEE INDENTURE Dated as of [ ]Indenture • June 8th, 2020 • Aikido Pharma Inc. • Services-commercial physical & biological research • New York
Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of the Securities issued under this Indenture.
INFORMATION IN THE MARKED SECTIONS OF THIS MASTER LICENSE AGREEMENT HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY FILED.Master License Agreement • June 8th, 2020 • Aikido Pharma Inc. • Services-commercial physical & biological research • Maryland
This Master License Agreement (“Agreement”) is effective as of the date of the last signature on the signature page (“Effective Date”) and is made by and between the University of Maryland, Baltimore (“University”), a public university that is part of the University System of Maryland (which is a public corporation and an instrumentality of the State of Maryland), and Aikido Pharma Inc., a Delaware corporation (“Company”) (collectively referred to as the “Parties”).
